Dongmei Zhang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Histone Deacetylase

Cardiovascular Disease

Top Venues

British journal of pharmacology

Nature metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Jiuguo Lin, Jiaojiao Wang, Jian Fang, Meihang Li, Suowen Xu, Peter J Little, Dongmei Zhang, Zhiping Liu
The cytoplasmic sensor, the AIM2 inflammasome: A precise therapeutic target in vascular and metabolic diseases. British journal of pharmacology (2024)
Jiuguo Lin, Jiaojiao Wang, Jian Fang, Meihang Li, Suowen Xu, Peter J Little, Dongmei Zhang, Zhiping Liu
The cytoplasmic sensor, the AIM2 inflammasome: A precise therapeutic target in vascular and metabolic diseases. British journal of pharmacology 181 (12) (2024)
Jiuguo Lin, Jiaojiao Wang, Jian Fang, Meihang Li, Suowen Xu, Peter J Little, Dongmei Zhang, Zhiping Liu
The cytoplasmic sensor, the AIM2 inflammasome: A precise therapeutic target in vascular and metabolic diseases. British journal of pharmacology 181 (12) (2024)
Chenran Wang, Maohua Huang, Yuning Lin, Yiming Zhang, Jing-Hua Pan, Chang Jiang, Minjing Cheng, Shenrong Li, Wen-Zhuo He, Zhengqiu Li, Zhengchao Tu, Jun Fan, Huhu Zeng, Jiahui Lin, Yongjin Wang, Nan Yao, Tongzheng Liu, Qi Qi, Xiangning Liu, Zhi-Min Zhang, Minfeng Chen, Liang-Ping Xia, Dongmei Zhang, Wen-Cai Ye
ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy. Nature metabolism (2023)